{"nct_id":"NCT01611090","title":"A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma","status":"COMPLETED","status_verified_date":"2020-02","start_date":"2012-09-19","start_date_type":"ACTUAL","primary_completion_date":"2019-01-23","primary_completion_date_type":"ACTUAL","completion_date":"2019-01-23","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["JNJ"]}